WHO is In Denial

Millions Risk Disease and Death Through Disinformation Campaigns and Billionaire Interference

The World Health Organization’s campaign against nicotine pouches reflects a pattern of alarmist advocacy that critics say ignores science, real-world outcomes, basic logic, and the sovereign right of governments to craft policy suited to their own public health needs. Rather than applying a risk-proportionate approach, the WHO has increasingly treated all nicotine products as though they pose the same danger as combustible cigarettes, despite the clear and well-established fact that combustion is the primary driver of tobacco-related disease. In doing so, the organisation is accused of overstating the risks of lower-risk products, understating their potential role in helping adults move away from smoking, and promoting a one-size-fits-all regulatory agenda that extends beyond its proper remit and undermines its claim to be guided by science.

This criticism is especially sharp in relation to the WHO Framework Convention on Tobacco Control (FCTC). Adopted in 2003 as the first international treaty negotiated under the auspices of the WHO, the FCTC explicitly states in Article 1(d) that tobacco control includes a combination of supply, demand, and harm-reduction strategies. That language reflects a broad and pragmatic public health principle: when immediate elimination of risk is not possible, reducing harm is a legitimate and necessary policy goal. Harm reduction is well established in other fields of public health, including HIV prevention, drug policy, and alcohol control. Against that background, the refusal of the FCTC system to meaningfully incorporate tobacco harm reduction into its policies stands out as a striking inconsistency.

Critics argue that this inconsistency has practical consequences. By attacking nicotine pouches and other smoke-free alternatives without properly accounting for relative risk, the WHO risks misleading policymakers and the public alike. Policies built on this approach may protect cigarettes from competition, push consumers toward illicit markets, and deny adult smokers access to products that are likely to be far less harmful than continuing to smoke. The result is not sound public health policy but a distorted framework that prioritises prohibitionist messaging over measurable health gains.

There is also growing concern that international pressure shaped by powerful philanthropic and commercial interests can end up narrowing the policy space available to national governments. For many critics, this is no longer just a debate about nicotine science; it is a question of institutional overreach, policy credibility, and sovereignty. If the WHO and the FCTC are serious about evidence-based tobacco control, they should return to the treaty’s own text, recognise the role of tobacco harm reduction, and support regulation that protects youth while preserving regulated adult access to lower-risk alternatives.

Its continued failure to do so risks even further erosion of trust in an already troubled institution

It is interesting to note that Argentina and the USA, who both recently threw their toys out of the WHO pram, have both rapidly reversed course on vaping regulations, with Argentina introducing a regulatory framework hat many observers say is a pragmatic and workable approach, and the USA finally looking as though it is starting to clear some of the thousands of product that have been pending for year and easing restrictions on flavoured e-juices.

Does this demonstrate a realization by these countries that membership in the WHO carries a responsibility to follow unhelpful, inappropriate and unsustainable policies to the detriment of their citizens and their sovereignty?

As WHO moves towards electing a new leader, it would be well advised to consider a reboot, changing its repressive, unscientific, billionaire corrupted prohibitionist stance against less harmful nicotine alternatives and focus on the FCTC’s core mission, that of ending the scourge of combustible tobacco.

We don’t ban aspirin because it upsets some user’s stomachs, we use it because the side effects are far less harmful than the condition it treats.

Pouches and vapes are the aspirins of tobacco control.

Until and unless WHO FCTC recognizes this fact its mission will remain compromised and unhelpful, resulting in even more deaths from combustible tobacco as far safer and effective avenues away from smoking are shut down to protect the “Tobacco Control” professionals whose money comes from the same sources as the FCTC, and whose careers would come to a crashing halt were the corrupted, prohibitionist disinformation rhetoric, and the funding sources driving it, to be fully exposed.

Time to turn the page, wake up and smell the vape, WHO…